Surgical Science Sweden AB (publ) (STO:SUS)
84.00
0.00 (0.00%)
Oct 31, 2025, 12:59 PM CET
STO:SUS Revenue
Surgical Science Sweden AB had revenue of 209.16M SEK in the quarter ending June 30, 2025, a decrease of -1.56%. This brings the company's revenue in the last twelve months to 943.23M, up 12.52% year-over-year. In the year 2024, Surgical Science Sweden AB had annual revenue of 884.09M with 0.14% growth.
Revenue (ttm)
943.23M
Revenue Growth
+12.52%
P/S Ratio
4.54
Revenue / Employee
2.88M
Employees
274
Market Cap
4.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 884.09M | 1.23M | 0.14% |
| Dec 31, 2023 | 882.85M | 80.31M | 10.01% |
| Dec 31, 2022 | 802.54M | 435.76M | 118.81% |
| Dec 31, 2021 | 366.78M | 261.98M | 249.98% |
| Dec 31, 2020 | 104.80M | 3.28M | 3.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |